cdmo.directory
← Compare landing

Codis vs CorePharma LLC

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/codis/corepharma

CategoryCodisCorePharma LLC
Listed sitecdmocdmo
SummaryGlobal CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities.Oral solid dosage contract manufacturer in Middlesex, NJ offering formulation development, analytical testing, tablet and capsule manufacturing, and blister or bottle packaging. Annual capacity exceeds 2 billion dosage units, and the site is FDA and DEA registered for Schedules II–V.
Services
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Oral Solid Dosage Manufacturing
  • Secondary Packaging & Labeling
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Oral Solid Dosage Manufacturing
  • Secondary Packaging & Labeling
Modalities
  • Small Molecule
Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, St. Louis, Missouri, USA
  • Microencapsulation & Continuous Granulation, St. Louis, Missouri, USA
  • Spray Drying & Commercial Manufacturing, Haverhill, England, UK
  • Manufacturing Facility, Nottingham, England, UK
  • Manufacturing Facility, Seymour, Indiana, USA
  • Wood Avenue (Headquarters), Middlesex, NJ, US
  • Lackland Drive, Middlesex, NJ, US
Certifications
  • FDA · Identifier: 21 CFR 210/211, 110/111, 117
  • German Authorities · Identifier: Manufacturing site GMP approval (Pharmaceutical Products Act)
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.